These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33459068)

  • 1. Inhibitors of prostate-specific membrane antigen in the diagnosis and therapy of metastatic prostate cancer - a review of patent literature.
    Ha H; Kwon H; Lim T; Jang J; Park SK; Byun Y
    Expert Opin Ther Pat; 2021 Jun; 31(6):525-547. PubMed ID: 33459068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen.
    Kim K; Kwon H; Barinka C; Motlova L; Nam S; Choi D; Ha H; Nam H; Son SH; Minn I; Pomper MG; Yang X; Kutil Z; Byun Y
    J Med Chem; 2020 Mar; 63(6):3261-3273. PubMed ID: 32097010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen.
    Mosayebnia M; Hajimahdi Z; Beiki D; Rezaeianpour M; Hajiramezanali M; Geramifar P; Sabzevari O; Amini M; Hatamabadi D; Shahhosseini S
    Bioorg Chem; 2020 Jun; 99():103743. PubMed ID: 32217372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives.
    Young JD; Ma MT; Eykyn TR; Atkinson RA; Abbate V; Cilibrizzi A; Hider RC; Blower PJ
    Bioorg Med Chem Lett; 2021 Jun; 42():128044. PubMed ID: 33865971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.
    Kratochwil C; Afshar-Oromieh A; Kopka K; Haberkorn U; Giesel FL
    Semin Nucl Med; 2016 Sep; 46(5):405-18. PubMed ID: 27553466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics.
    Kumar A; Mastren T; Wang B; Hsieh JT; Hao G; Sun X
    Bioconjug Chem; 2016 Jul; 27(7):1681-9. PubMed ID: 27248781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel.
    Saniee F; Shabani Ravari N; Goodarzi N; Amini M; Atyabi F; Saeedian Moghadam E; Dinarvand R
    Pharm Dev Technol; 2021 Apr; 26(4):381-389. PubMed ID: 33538232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary evaluation of
    Vaidyanathan G; Mease RC; Minn I; Choi J; Chen Y; Shallal H; Kang CM; McDougald D; Kumar V; Pomper MG; Zalutsky MR
    Nucl Med Biol; 2021; 94-95():67-80. PubMed ID: 33601187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer.
    Pillai MRA; Nanabala R; Joy A; Sasikumar A; Russ Knapp FF
    Nucl Med Biol; 2016 Nov; 43(11):692-720. PubMed ID: 27589333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy.
    Maes J; Gesquière S; De Spiegeleer A; Maes A; Van de Wiele C
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.
    Eder M; Schäfer M; Bauder-Wüst U; Hull WE; Wängler C; Mier W; Haberkorn U; Eisenhut M
    Bioconjug Chem; 2012 Apr; 23(4):688-97. PubMed ID: 22369515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy.
    Umbricht CA; Benešová M; Schibli R; Müller C
    Mol Pharm; 2018 Jun; 15(6):2297-2306. PubMed ID: 29684274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel multifunctional
    Kwon YD; Lee JY; La MT; Lee SJ; Lee SH; Park JH; Kim HK
    Eur J Med Chem; 2020 Mar; 189():112099. PubMed ID: 32014792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
    Hillier SM; Maresca KP; Lu G; Merkin RD; Marquis JC; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    J Nucl Med; 2013 Aug; 54(8):1369-76. PubMed ID: 23733925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Radiolabeling of Glu-Urea-Lys with
    Hatamabadi D; Joukar S; Shakeri P; Balalaie S; Yazdani A; Khoramjouy M; Mazidi SM; Kobarfard F; Mosayebnia M; Bozorgchami N; Ahmadi M; Ayyoubzadeh SM; Shahhosseini S
    Cancer Biother Radiopharm; 2023 Sep; 38(7):486-496. PubMed ID: 37578479
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand.
    Kularatne SA; Wang K; Santhapuram HK; Low PS
    Mol Pharm; 2009; 6(3):780-9. PubMed ID: 19361233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.
    Baranski AC; Schäfer M; Bauder-Wüst U; Roscher M; Schmidt J; Stenau E; Simpfendörfer T; Teber D; Maier-Hein L; Hadaschik B; Haberkorn U; Eder M; Kopka K
    J Nucl Med; 2018 Apr; 59(4):639-645. PubMed ID: 29191856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSMA-targeted dendrimers: a patent evaluation (WO2012078534).
    Akhtar NH; Osborne JR; Fareedy SB; Tagawa ST
    Expert Opin Ther Pat; 2013 May; 23(5):665-8. PubMed ID: 23581819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.
    Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H
    J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic radiosynthesis of a
    Lowe PT; Dall'Angelo S; Fleming IN; Piras M; Zanda M; O'Hagan D
    Org Biomol Chem; 2019 Feb; 17(6):1480-1486. PubMed ID: 30681115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.